Other forms of sporotrichosis
ICD-10 B42.89 is a billable code used to indicate a diagnosis of other forms of sporotrichosis.
Sporotrichosis is a fungal infection caused by the dimorphic fungus Sporothrix schenckii, which is commonly found in soil, plants, and decaying organic matter. The infection typically manifests as cutaneous lesions, but can also disseminate to other systems, particularly in immunocompromised patients. Other forms of sporotrichosis may include lymphocutaneous sporotrichosis, which is characterized by nodular lesions that follow lymphatic drainage, and disseminated sporotrichosis, which can affect multiple organs. In immunocompromised individuals, such as those with HIV/AIDS or undergoing chemotherapy, the risk of severe manifestations increases significantly. Diagnosis is primarily clinical, supported by culture or histopathological examination. Treatment usually involves antifungal medications such as itraconazole or potassium iodide, but may require more aggressive therapy in severe cases. Accurate coding for sporotrichosis is essential for proper treatment management and epidemiological tracking.
Detailed clinical history, laboratory results, and treatment plans.
Patients presenting with skin lesions, systemic symptoms, or those with known exposure to potential sources of infection.
Ensure documentation reflects the severity and extent of the disease, especially in immunocompromised patients.
Photographic evidence of lesions, biopsy results, and treatment response.
Patients with chronic skin lesions that do not respond to standard treatments.
Document the duration of lesions and any prior treatments to support the diagnosis.
When a skin lesion is excised for biopsy to confirm sporotrichosis.
Document the size, location, and characteristics of the lesion.
Ensure the procedure is linked to the diagnosis of sporotrichosis.
Sporotrichosis is a fungal infection caused by Sporothrix schenckii, often presenting as skin lesions but can disseminate in immunocompromised individuals.
Treatment typically involves antifungal medications such as itraconazole or potassium iodide, with more aggressive therapy required for severe cases.
